High expression of SLC34A2 is a favorable prognostic marker in lung adenocarcinoma patients
Dysregulation of SLC34A2 (NaPi2b) in tumors has attracted wide attention, but its expression and function in non–small cell lung cancer remains unclear. By examining its expression in lung adenocarcinoma and correlation to patient outcome, we aimed to explore its prognostic and therapeutic values in...
Main Authors: | Zhaoxuan Zhang, Shan Ye, Min Zhang, Jing Wu, Hong Yan, Xiaojie Li, Jie He |
---|---|
Format: | Article |
Language: | English |
Published: |
IOS Press
2017-07-01
|
Series: | Tumor Biology |
Online Access: | https://doi.org/10.1177/1010428317720212 |
Similar Items
-
SLC15A4 Serves as a Novel Prognostic Biomarker and Target for Lung Adenocarcinoma
by: Hui Huang, et al.
Published: (2021-06-01) -
Presence of a 34-gene signature is a favorable prognostic marker in squamous non-small cell lung carcinoma
by: W. S. M. E. Theelen, et al.
Published: (2020-07-01) -
Schlafen 12 Is Prognostically Favorable and Reduces C-Myc and Proliferation in Lung Adenocarcinoma but Not in Lung Squamous Cell Carcinoma
by: Sarmad Al-Marsoummi, et al.
Published: (2020-09-01) -
SLC2A5 Correlated with Immune Infiltration: A Candidate Diagnostic and Prognostic Biomarker for Lung Adenocarcinoma
by: Lianxiang Luo, et al.
Published: (2021-01-01) -
HLA-DQB1 expression on tumor cells is a novel favorable prognostic factor for relapse in early-stage lung adenocarcinoma
by: Zhang L, et al.
Published: (2019-04-01)